1-3 of 3
Jay S. Wunder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B027: The development of a multiscale transcriptional atlas of sarcoma

Joshua O. Nash, Federico Comitani, Rose Chami, Sarah Cohen-Gogo, Astra Chang-Schwertschkow, Yael Babichev, Jodi Lees, Noa Alon, Nalan Gokgoz, Stephen Man Yu, Kyoko Yuki, Miranda Lorenti, Zhanqin Liu, Alaina McGoey, Famida Spatare, Bernarld Castro, Kim Tsoi, Hagit Peretz Soroka, Jack Brzezinski, Anita Villani, Albiruni Razak, Abha Gupta, Elizabeth Demicco, Gino Somers, Brendan C. Dickson, Jay S. Wunder, Irene L. Andrulis, David Malkin, Rebecca A. Gladdy, Adam Shlien
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): B027.
https://doi.org/10.1158/1557-3265.SARCOMAS22-B027
Published: 15 September 2022
View article titled, Abstract B027: The development of a multiscale transcriptional atlas of sarcoma
Journal Articles

Abstract B39: Investigation of the effects of alterations in the glutamate receptor, GRIK2, on osteosarcoma tumorigenesis

Justin G. Mayers, Nalan Gokgoz, Jay S. Wunder, Irene L. Andrulis
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2_Supplement): B39.
https://doi.org/10.1158/1557-3265.SARCOMAS17-B39
Published: 15 January 2018
View article titled, Abstract B39: Investigation of the effects of alterations in the glutamate receptor, GRIK2, on osteosarcoma tumorigenesis
Journal Articles

Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma

Kårstein Måseide, Rita A. Kandel, Robert S. Bell, Charles N. Catton, Brian O’Sullivan, Jay S. Wunder, Melania Pintilie, David Hedley, Richard P. Hill
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4464–4471.
https://doi.org/10.1158/1078-0432.CCR-03-0541
Published: 06 July 2004
View article titled, Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma
Open the PDF for Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma in another window